Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics

Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics

Source: 
Fierce Pharma
snippet: 

Colorado is making a play for a Japanese CDMO in hopes it will invest about $100 million in an empty AstraZeneca plant in Boulder. It just isn’t saying who it is.

Development officials have put together a package of about $6.5 million in tax incentives for what it has code-named Project Blizzard. The Colorado Daily reports there are inferences the CDMO is AGC Biologics. Documents indicated the CDMO would invest about $100 million in the facility and create 280 new jobs.